ALAMEDA, Calif., May 1, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company developing innovative therapies for the treatment of chronic neurological conditions, announced today that Chief Business Officer Michael Coffee will present information on Avigen’s 2007 development programs and product pipeline at the annual BIO International Convention in Boston. Mr. Coffee will be participating in the Business Forum, and will present on Tuesday, May 8, 2007, from 2:45 to 3:00 p.m. EDT in Room D, Level One, of the Boston Convention & Exhibition Center.
